Evidence map›Paper›PMID 38201322›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Machine Learning Approach for Improved Longitudinal Prediction of Progression from Mild Cognitive Impairment to Alzheimer's Disease.

Robert P Adelson, Anurag Garikipati, Jenish Maharjan, Madalina Ciobanu, Gina Barnes, Navan Preet Singh, Frank A Dinenno, Qingqing Mao, Ritankar Das

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Robert P AdelsonMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.ORCID 0000-0002-0888-5638
Anurag GarikipatiMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.
Jenish MaharjanMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.
Madalina CiobanuMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.ORCID 0000-0002-0608-4394
Gina BarnesMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.
Navan Preet SinghMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.ORCID 0000-0002-9563-1598
Frank A DinennoMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.
Qingqing MaoMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.ORCID 0000-0001-6001-6723
Ritankar DasMontera, Inc. dba Forta, 548 Market St, PMB 89605, San Francisco, CA 94104-5401, USA.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Mild cognitive impairment (MCI) is cognitive decline that can indicate future risk of Alzheimer's disease (AD). We developed and validated a machine learning algorithm (MLA), based on a gradient-boosted tree ensemble method, to analyze phenotypic data for individuals 55-88 years old (

Indexed as

Alzheimer’s diseasedisease progressionmachine learningmild cognitive impairment

Identifiers

PMID38201322
PMCPMC10795823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.